View Author
Prosper, D.M.
( D.M. Prosper)
patient eptifibatide nonfatal mi angina group 0.001 treatment trial pursuit angiography 30 days nonfatal model outcome pursuit trial population angiographic elevation nonst-segment elevation acs event death nomogram disease baseline enrollment circulation syndrome characteristic 6 months point predictor j cardiol /iiia gusto-iib population end point lesion probability benefit analysis artery disease cardiol table angiographic findings study artery incidence st-segment investigator gusto-iib month troponin levels c-index value stenosi heart 5767 patients pursuit population nonst-segment placebo coll cardiol enrollment mi intracoronary thrombus baseline characteristics surgery troponin 3 groups factor morphology committee finding infarction figure value angioplasty level intracoronary events committee nonstsegment elevation acs randomization 1.2 end points
1 Most Recent Publications
|
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators
(Article)
Roe, M.T. Vahanian, A. Ohman, E.M. Karsch, K. Kitt, M.M. Ruzyllo, W. Akkerhuis, K.M. Harrington, R.A. Prosper, D.M. Pieper, K.S. Topol, E.J. Bhatt, D.L. Lincoff, A.M. Simoons, M.L. Califf, R.M. |
2000-01-01
|